Klinikum Oldenburg GmbH Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2004
NCT00153998
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

Klinikum Oldenburg GmbH, Dr.-Eden-Str.10; 26133 Oldenburg

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liver Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 5